Pippa Hopkinson

642 total citations
11 papers, 446 citations indexed

About

Pippa Hopkinson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Pippa Hopkinson has authored 11 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 3 papers in Immunology and Allergy. Recurrent topics in Pippa Hopkinson's work include Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Pippa Hopkinson is often cited by papers focused on Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Pippa Hopkinson collaborates with scholars based in United Kingdom. Pippa Hopkinson's co-authors include Brian J. Lipworth, Peter T. Donnan, Allan D. Struthers, Sriram Vaidyanathan, Martyn Barnes, Peter J. Williamson, Li Wei, Faisel Khan, George Casella and Thenmalar Vadiveloo and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Pippa Hopkinson

11 papers receiving 430 citations

Peers

Pippa Hopkinson
Alistair Aaronson United States
V. Backer Denmark
Andrew Simmons United Kingdom
Heqiong Wang United States
E Cserháti Hungary
Shefali Samant United States
Agnes S. Sundaresan United States
Alistair Aaronson United States
Pippa Hopkinson
Citations per year, relative to Pippa Hopkinson Pippa Hopkinson (= 1×) peers Alistair Aaronson

Countries citing papers authored by Pippa Hopkinson

Since Specialization
Citations

This map shows the geographic impact of Pippa Hopkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pippa Hopkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pippa Hopkinson more than expected).

Fields of papers citing papers by Pippa Hopkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pippa Hopkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pippa Hopkinson. The network helps show where Pippa Hopkinson may publish in the future.

Co-authorship network of co-authors of Pippa Hopkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Pippa Hopkinson. A scholar is included among the top collaborators of Pippa Hopkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pippa Hopkinson. Pippa Hopkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Casella, George, Thenmalar Vadiveloo, Sheila Ireland, et al.. (2019). Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes. Journal of the American College of Cardiology. 74(25). 3112–3120. 144 indexed citations
2.
Lipworth, Brian J., et al.. (2014). Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial. The Lancet Respiratory Medicine. 2(4). 293–300. 88 indexed citations
3.
Hopkinson, Pippa, et al.. (2013). Do phosphodiesterase 5 inhibitors improve exercise capacity in patients with COPD associated pulmonary hypertension? (3P study). European Respiratory Journal. 42(Suppl 57). P4063–P4063. 1 indexed citations
4.
Hopkinson, Pippa, et al.. (2012). The effects of sildenafil on lung function in COPD. 40. 2188. 2 indexed citations
5.
Vaidyanathan, Sriram, Martyn Barnes, Peter J. Williamson, et al.. (2011). Treatment of Chronic Rhinosinusitis With Nasal Polyposis With Oral Steroids Followed by Topical Steroids. Annals of Internal Medicine. 154(5). 293–302. 131 indexed citations
6.
Williamson, Peter A., et al.. (2010). Disconnect between standardized field‐based testing and mannitol challenge in Scottish elite swimmers. Clinical & Experimental Allergy. 40(5). 731–737. 23 indexed citations
7.
Williamson, Peter A., et al.. (2010). P172 Fluticasone/salmeterol combination confers significant benefits in smoking asthmatics. Thorax. 65(Suppl 4). A150–A151. 1 indexed citations
8.
Nair, Arun, Daniel Menzies, Pippa Hopkinson, Lesley C. McFarlane, & Brian J. Lipworth. (2009). In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti‐static spacers and a metered dose inhaler. British Journal of Clinical Pharmacology. 67(2). 191–198. 11 indexed citations
9.
Menzies, Daniel, et al.. (2008). Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. Journal of Allergy and Clinical Immunology. 121(5). 1184–1189.e4. 14 indexed citations
10.
Menzies, Daniel, Ajith Nair, Pippa Hopkinson, Lesley C. McFarlane, & Brian J. Lipworth. (2007). Differential anti‐inflammatory effects of large and small particle size inhaled corticosteroids in asthma. Allergy. 62(6). 661–667. 23 indexed citations
11.
Barnes, Martyn, Daniel Menzies, Arun Nair, Pippa Hopkinson, & Brian J. Lipworth. (2007). A proof‐of‐concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge. Clinical & Experimental Allergy. 37(5). 696–703. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026